Impact of nirsevimab immunization on pediatric RSV-related hospitalizations in Luxembourg

Respiratory syncytial virus (RSV) is one of the main reasons leading to hospitalization among young children worldwide and each year, an estimated 101,000 children below the age of 5 years die due to RSV infections.

Related Keywords

Luxembourg , ,European Union ,European Centre For Disease Prevention ,Disease Prevention ,European Economic Area ,Respiratory ,Respiratory Syncytial Virus ,Virus ,Ntibody ,Children ,Laboratory ,Monoclonal Antibody ,Prophylaxis ,Research ,